首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Protein crystallization with microseed matrix screening: application to human germline antibody Fabs
【2h】

Protein crystallization with microseed matrix screening: application to human germline antibody Fabs

机译:微晶基质筛选的蛋白质结晶:在人种系抗体Fabs中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The crystallization of 16 human antibody Fab fragments constructed from all pairs of four different heavy chains and four different light chains was enabled by employing microseed matrix screening (MMS). In initial screening, diffraction-quality crystals were obtained for only three Fabs, while many Fabs produced hits that required optimization. Application of MMS, using the initial screens and/or refinement screens, resulted in diffraction-quality crystals of these Fabs. Five Fabs that failed to give hits in the initial screen were crystallized by cross-seeding MMS followed by MMS optimization. The crystallization protocols and strategies that resulted in structure determination of all 16 Fabs are presented. These results illustrate the power of MMS and provide a basis for developing future strategies for macromolecular crystallization.
机译:通过使用微种子基质筛选(MMS),可以实现由四个不同重链和四个不同轻链的所有对构成的16个人抗体Fab片段的结晶。在最初的筛选中,仅三个Fab获得了衍射质量的晶体,而许多Fab产生的命中需要优化。使用初始屏幕和/或精制屏幕应用MMS,可以得到这些Fab的衍射质量晶体。通过交叉播种MMS和随后的MMS优化,结晶出了五个未能在初始筛选中获得成功的Fab。介绍了导致所有16个Fab的结构确定的结晶方案和策略。这些结果说明了MMS的功能,并为开发未来的大分子结晶策略提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号